Stockscreener 앱 받기
12.04
6.67%
0.795
전일 마감가:
$11.25
열려 있는:
$12.13
하루 거래량:
11,057
Relative Volume:
0.25
시가총액:
$36.56M
수익:
-
순이익/손실:
$-53.45M
주가수익비율:
-0.5548
EPS:
-21.71
순현금흐름:
$-31.81M
1주 성능:
+4.17%
1개월 성능:
-10.85%
6개월 성능:
+39.21%
1년 성능:
+53.94%
1일 변동 폭
$11.63
$12.99
1주일 범위
$10.55
$12.99
52주 변동 폭
$5.9999
$18.17
Surrozen Inc Stock (SRZN) Company Profile
명칭
Surrozen Inc
전화
650-475-2820
주소
171 OYSTER POINT BLVD, SOUTH SAN FRANCISCO
SRZN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SRZN
Surrozen Inc
|
12.00 | 36.56M | 0 | -53.45M | -31.81M | -21.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.45 | 113.70B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
683.16 | 75.52B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
665.74 | 39.78B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.41 | 35.34B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.06 | 29.05B | 3.30B | -501.07M | 1.03B | -2.1146 |
Surrozen Inc Stock (SRZN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-03 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2021-10-11 | 개시 | BofA Securities | Buy |
| 2021-09-15 | 개시 | Guggenheim | Buy |
| 2021-09-07 | 개시 | Stifel | Buy |
Surrozen Inc 주식(SRZN)의 최신 뉴스
This Worthington Enterprises Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
HC Wainwright Initiates Coverage on Surrozen With Buy Rating, $32 Price Target -January 30, 2025 at 08:15 am EST - Marketscreener.com
H.C. Wainwright sets $32 target on Surrozen stock with Buy rating - Investing.com
(SRZN) Trading Advice - Stock Traders Daily
REGENTS OF THE UNIVERSITY OF CALIFORNIA Acquires Shares in Surro - GuruFocus.com
Here's Why We're A Bit Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Situation - Yahoo Finance
(SRZN) Trading Report - Stock Traders Daily
Financial Analysis: Recursion Pharmaceuticals (NASDAQ:RXRX) versus Surrozen (NASDAQ:SRZN) - Defense World
Surrozen exec vice president sells $14,642 in stock - Investing.com
Surrozen exec vice president sells $14,642 in stock By Investing.com - Investing.com UK
Surrozen's CFO and COO sells $20,513 in stock - Investing.com
Surrozen's CFO and COO sells $20,513 in stock By Investing.com - Investing.com UK
Surrozen (NASDAQ:SRZN) Upgraded by Guggenheim to “Buy” Rating - Defense World
Surrozen stock soars to 52-week high, hits $16.35 - Investing.com
(SRZN) Investment Analysis and Advice - Stock Traders Daily
Financial Review: Surrozen (NASDAQ:SRZN) & Vericel (NASDAQ:VCEL) - Defense World
Learn to Evaluate (SRZN) using the Charts - Stock Traders Daily
When the Price of (SRZN) Talks, People Listen - Stock Traders Daily
Companies Like Surrozen (NASDAQ:SRZN) Could Be Quite Risky - Simply Wall St
Contrasting Vigil Neuroscience (NASDAQ:VIGL) and Surrozen (NASDAQ:SRZN) - Defense World
Surrozen, Inc.: Q3 2024 Earnings Overview - TipRanks
Trading (SRZN) With Integrated Risk Controls - Stock Traders Daily
Alyeska Investment Group L.P. Expands Portfolio with Surrozen In - GuruFocus.com
Surrozen (NASDAQ:SRZN) Stock Price Down 7% – Here’s Why - Defense World
Stonepine Capital Management, LLC Increases Stake in Surrozen Inc - GuruFocus.com
Goldman Sachs Group Inc's Strategic Investment in Surrozen Inc - GuruFocus.com
Surrozen to Present at Upcoming Healthcare Investor Conferences - The Manila Times
Surrozen (SRZN) to Present at Guggenheim and Stifel Healthcare Conferences | SRZN Stock News - StockTitan
Surrozen Provides Third Quarter 2024 Financial Results and Business Update - ForexTV.com
(SRZN) Trading Signals - Stock Traders Daily
Surrozen partners with TCGFB for lung disease therapy By Investing.com - Investing.com Canada
Surrozen partners with TCGFB for lung disease therapy - Investing.com India
Surrozen and TCGFB, Inc. Announce Strategic Research Collaboration to Develop TGF-β Antibodies for Idiopathic Pulmonary Fibrosis - The Manila Times
The Column Group's biotech taps Surrozen for lung disease research pact - Fierce Biotech
StemPoint Capital LP Increases Stake in Surrozen Inc - GuruFocus.com
Trend Tracker for (SRZN) - Stock Traders Daily
Surrozen (NASDAQ:SRZN) Trading Up 4.3% – Here’s What Happened - Defense World
How To Trade (SRZN) - Stock Traders Daily
This Week's Bay Area Deal Sheet (October 10, 2024) - Bisnow
Surrozen extends South San Francisco headquarters lease By Investing.com - Investing.com Australia
Surrozen extends South San Francisco headquarters lease - Investing.com India
187,206 Shares in Surrozen, Inc. (NASDAQ:SRZN) Purchased by Nantahala Capital Management LLC - Defense World
Stonepine Capital Management LLC Invests $724,000 in Surrozen, Inc. (NASDAQ:SRZN) - Defense World
CVI Holdings LLC Makes New Investment in Surrozen, Inc. (NASDAQ:SRZN) - Defense World
Column Group LLC Makes New Investment in Surrozen, Inc. (NASDAQ:SRZNW) - Defense World
Boehringer Ingelheim to advance SZN-413 for retinal diseases - BioWorld Online
Patrick Brennan joins Selective Insurance as CFO - Reinsurance News
Surrozen and Boehringer Ingelheim advance SZN-413 development By Investing.com - Investing.com South Africa
Streamline Health CEO buys $1,008 in company stock By Investing.com - Investing.com UK
Selective Insurance appoints Patrick Brennan as chief financial officer - ROI-NJ.com
Surrozen and Boehringer Ingelheim advance SZN-413 development - Investing.com India
Surrozen Inc (SRZN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
4.93%
자본화:
|
볼륨(24시간):